일양약품우
7,070KRWMarket close of 10/27 (Tue)
Down -0.42%-30KRWMarket close of 10/27 (Tue)
Preliminary value — replaced once official KRX data for the same date is publishedClose of 10/28 (Wed)7,050KRWDown -0.28%
Preliminary · replaced once official KRX data for the same date is published
- Open
- 7,100
- High
- 7,100
- Low
- 7,010
- Day range
- Day range low 7,010 high 7,100, open 7,100, close 7,070, previous close 7,100
- Volume
- 0×10K shares
- 210,540 KRW 0.11× the 20-session average
Market close of 10/27 (Tue)
Where it sits in the 1-year range
2%2% of the way up from the lowest close in 1 year (252 sessions) · -54.5% from the high
Free · no sign-inSource from 2021-05-17
Points to check
- Earningsto check-5.8B KRWOperating income over the last four quarters -5.8B KRW (loss)
- Recent filingsnot verifiedOutside filing data coverage, so not verified
- Foreign & institutionalnot verifiedOutside investor-flow coverage, so not verified
The other 2 are within the usual range
- Daily move-0.42%usual range
- Trading value0.1×usual range
See the full check report
Quarterly results · Q1 2026
- Revenue65.1B KRW
- vs. year ago
- +5.0%
- vs. prior quarter
- -17.5%
- Operating income-7.4B KRW
- vs. year ago
- Turned to loss
- vs. prior quarter
- Turned to loss
- Operating margin-11.3%
- vs. year ago
- -16.8 pp
- vs. prior quarter
- -12.0 pp
Quarterly operating income trend
Same sector · 제약
Down -2.22%· 88 of 168 stocks up, preferred shares excluded · trading value 553.0B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +0.6% | Down -5.37% | 124.5B KRW |
| 셀트리온 | Close over the last 20 sessions +6.3% | Down -0.74% | 82.4B KRW |
| 지투지바이오 | Close over the last 20 sessions +22.2% | Down -13.38% | 46.9B KRW |
| 한미약품 | Close over the last 20 sessions -32.6% | Down -0.57% | 25.5B KRW |
| 에스티팜 | Close over the last 20 sessions -11.9% | Down -9.15% | 21.4B KRW |
Other share classes of this company · 일양약품
Schedule
- Next data 10/29 (Thu) after 08:50
Related news
Tables, financials, investor flows and filing history are in the Detailed view.
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 82% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.